Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Ott

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Hepatology (Baltimore, Md.)|July 28, 2021
Designing Clinical Trials in Wilson's DiseasePeter Ott, Aftab Ala, Frederick K Askari, et al.
JHEP Reports : Innovation in Hepatology|October 27, 2023
Distribution of non-ceruloplasmin-bound copper after i.v. <sup>64</sup>Cu injection studied with PET/CT in patients with Wilson diseaseDitte Emilie Munk, Mikkel Holm Vendelbo, Frederik Teicher Kirk, et al.
Frontiers in Neuroscience|November 19, 2014
Oxidative metabolism of astrocytes is not reduced in hepatic encephalopathy: a PET study with [(11)C]acetate in humansPeter Iversen, Kim Mouridsen, Mikkel B Hansen, et al.
Plos One|January 3, 2018
Sleep in patients with disorders of consciousness characterized by means of machine learningTomasz Wielek, Julia Lechinger, Malgorzata Wislowska, et al.
Ugeskrift for Laeger|November 7, 2008
[Liver biopsy in liver patients with coagulopathy]Peter Ott, Henning Grønbaek, Jens Otto Clemmesen, et al.
Gastroenterology|December 2, 2008
Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathyPeter Iversen, Michael Sørensen, Lasse Kristoffer Bak, et al.
Hepatology (Baltimore, Md.)|November 13, 2021
The pathophysiology of Wilson's disease visualized: A human <sup>64</sup> Cu PET studyThomas Damgaard Sandahl, Lars C Gormsen, Kristoffer Kjærgaard, et al.
Journal of Hepatology|September 20, 2020
A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCAGideon M Hirschfield, Ulrich Beuers, Limas Kupcinskas, et al.
British Journal of Pharmacology|September 2, 2025
Methanobactin rapidly facilitates biliary copper excretion in a Wilson disease rat model visualised by <sup>64</sup>Cu PET/MRIEmilie Munk Lynderup, Mikkel Holm Vendelbo, Frederik Teicher Kirk, et al.
Orphanet Journal of Rare Diseases|July 4, 2020
The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's diseaseEmilie Glavind, Daniel N Gotthardt, Jan Pfeiffenberger, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Hepatology (Baltimore, Md.)|July 28, 2021
Designing Clinical Trials in Wilson's DiseasePeter Ott, Aftab Ala, Frederick K Askari, et al.
JHEP Reports : Innovation in Hepatology|October 27, 2023
Distribution of non-ceruloplasmin-bound copper after i.v. <sup>64</sup>Cu injection studied with PET/CT in patients with Wilson diseaseDitte Emilie Munk, Mikkel Holm Vendelbo, Frederik Teicher Kirk, et al.
Frontiers in Neuroscience|November 19, 2014
Oxidative metabolism of astrocytes is not reduced in hepatic encephalopathy: a PET study with [(11)C]acetate in humansPeter Iversen, Kim Mouridsen, Mikkel B Hansen, et al.
Plos One|January 3, 2018
Sleep in patients with disorders of consciousness characterized by means of machine learningTomasz Wielek, Julia Lechinger, Malgorzata Wislowska, et al.
Ugeskrift for Laeger|November 7, 2008
[Liver biopsy in liver patients with coagulopathy]Peter Ott, Henning Grønbaek, Jens Otto Clemmesen, et al.
Gastroenterology|December 2, 2008
Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathyPeter Iversen, Michael Sørensen, Lasse Kristoffer Bak, et al.
Hepatology (Baltimore, Md.)|November 13, 2021
The pathophysiology of Wilson's disease visualized: A human <sup>64</sup> Cu PET studyThomas Damgaard Sandahl, Lars C Gormsen, Kristoffer Kjærgaard, et al.
Journal of Hepatology|September 20, 2020
A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCAGideon M Hirschfield, Ulrich Beuers, Limas Kupcinskas, et al.
British Journal of Pharmacology|September 2, 2025
Methanobactin rapidly facilitates biliary copper excretion in a Wilson disease rat model visualised by <sup>64</sup>Cu PET/MRIEmilie Munk Lynderup, Mikkel Holm Vendelbo, Frederik Teicher Kirk, et al.
Orphanet Journal of Rare Diseases|July 4, 2020
The macrophage activation marker soluble CD163 is elevated and associated with liver disease phenotype in patients with Wilson's diseaseEmilie Glavind, Daniel N Gotthardt, Jan Pfeiffenberger, et al.
Pageof 16